Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

NCT04784455 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped The early termination of this study is a business decision following a portfolio reprioritization plan. The decision is not related to any Efficacy, Safety or Clinical concerns regarding Nomacopan/rVA576

Conditions

Interventions

Sponsor

AKARI Therapeutics